Mitchell Finer

Director/Board Member chez TURMERIC ACQUISITION CORP. Fortune : 60 555 $ au 31/12/2023

Profil

Mitchell H.
Finer founded Cell Genesys, Inc. in 1989, where he worked as Vice President-Research from 1989 to 1999, Adverum Biotechnologies, Inc. in 2006, where he worked as Director from 2006 to 2019, Oncorus, Inc. in 2015, where he worked as Director in 2023, CODA Biotherapeutics, Inc. in 2014, where he is working as Director from 2014, and ElevateBio LLC in 2017, where he is working as Director, President-Research & Development from 2017.
Dr. Finer also founded Abgenix, Inc., where he worked as Principal.
Dr. Finer also currently works at LifeEDIT Therapeutics, Inc., as Chief Executive Officer, Semma Therapeutics, Inc., as Director from 2015, Turmeric Acquisition Corp., as Independent Director, Abata Therapeutics, Inc., as Director, Tabby Therapeutics Ltd., as Director, and Elevatebio Base Camp, Inc., as President from 2019.
Dr. Finer also formerly worked at Intracel Corp., as Chief Executive Officer from 2005 to 2007, Genteric, Inc., as President & Chief Executive Officer from 2003 to 2005, Intracel Resources LLC, as Chief Executive Officer, Intracel Holdings Corp., as Chief Executive Officer from 2005 to 2008, MPM BioImpact, Inc, as Managing Director, Candel Therapeutics, Inc., as Director, TCR2 Therapeutics, Inc., as Independent Director from 2015 to 2020, SaviCorp, as Vice President-Research & Development, ViaCyte, Inc., as Senior Vice President-Development from 2008 to 2010, Aventis Pharmaceuticals, Inc., as Vice President-Gencell Division from 1999 to 2002, Sanofi India Ltd., as Vice President-Research, and bluebird bio, Inc., as Chief Scientific Officer from 2010 to 2015.
Dr. Finer received his doctorate degree in 1986 from Harvard University and undergraduate degree in 1979 from the University of California, Berkeley.

Détentions connues dans des sociétés publiques

Société	Date	Nombre d'actions	Valorisation	Date de valorisation
ONCORUS, INC. 1,84%	31/03/2023	480 598 ( 1,84% )	60 555 $	31/12/2023

Postes actifs de Mitchell Finer

Sociétés	Poste	Début
TURMERIC ACQUISITION CORP.	Director/Board Member	-
LifeEDIT Therapeutics, Inc.	Chief Executive Officer	-
Abata Therapeutics, Inc.	Director/Board Member	-
Elevatebio Base Camp, Inc.	President	01/05/2019
ElevateBio LLC	Founder	01/12/2017
CODA Biotherapeutics, Inc.	Founder	01/01/2014
Semma Therapeutics, Inc.	Director/Board Member	01/04/2015
Tabby Therapeutics Ltd.	Director/Board Member	-

Anciens postes connus de Mitchell Finer

Sociétés	Poste	Fin
ONCORUS, INC.	Chief Executive Officer	01/07/2018
░░░░ ░░░░░░░░░░░░ ░░░░	░░░░░░░░░░░░░░ ░░░░░░	░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░	░░░░░░░	░░░░░░░░░░
░░░░░░░░ ░░░░ ░░░░	░░░░░ ░░░░░░░░░░░░ ░░░░░░░	░░░░░░░░░░
░░░░░░░░ ░░░░	░░░░░░░░░ ░░░░░░░░░░░░░░░░░	░░░░░░░░░░

Formation de Mitchell Finer

Harvard University	Doctorate Degree
University of California, Berkeley	Undergraduate Degree